New Product

Discussion in 'Bioventus' started by Anonymous, Dec 30, 2013 at 9:09 PM.

Tags: Add Tags
  1. Anonymous

    Anonymous Guest

    When and What?
     

  2. Anonymous

    Anonymous Guest

    Nothing and never
     
  3. Anonymous

    Anonymous Guest

    Believe it when I see it. Perhaps a new
     
  4. Anonymous

    Anonymous Guest

    Nadda. Nothing ever. Soon, the old dudes will be in Flordia or California with all the other old farts.
     
  5. Anonymous

    Anonymous Guest

    let's talk about the "almost" products added to the portfolio.
     
  6. Anonymous

    Anonymous Guest

    Who would want US to sell their products? We don't even have decent data?
     
  7. Anonymous

    Anonymous Guest

    PEMF Bone Stim.
     
  8. Anonymous

    Anonymous Guest

    We don't go into the OR Suite. We don't sell pharmacueticals. We are a DME company and DME driven so we should sell braces or some other DME. Let's get over trying to make us something we are Not. We are light years behind tissue products, grafting etc and we don't have a sales force who can sell these type products. Bunch of whiners.
     
  9. Anonymous

    Anonymous Guest

    I just do not understand why, as an ortho device group, why we need to prove reach and frequency to a potential partner or supplier. Do trauma or spine reps have reach and frequency? Some of those reps only have 2 or 3 docs.
    I think we are trying to look better for a potential buyer.
     
  10. Anonymous

    Anonymous Guest

    The 2 above posts are about as accurate as they can be on this board.
     
  11. Anonymous

    Anonymous Guest

    Agreed!!! Let's get braces and call it a day. DME fitters. Really, biologics? Haha.
     
  12. Anonymous

    Anonymous Guest

    Of course! If anybody can't see this; they are blind.
     
  13. Anonymous

    Anonymous Guest

    Reach and frequency is a "pharma" mentality. You have to realize that the management in place now is not of an ortho mentality. Most of them are J&J drop outs or "has beens" whose shirts weren't quite "crisp" enough.

    If they wanted "reach" and "frequency" why did they "pink slip" 50 plus reps? Doesn't make sense because "reach" and "frequency" is best achieved by numbers.

    This is not pharma. This is DME and DME- sales, paper pushing and fitting. The best action management can do is to hire more people if they want to achieve this goal. Reps can only physically, properly manage about 50 or so writers. Some of our reps have 150 or more in their universe. More than likely out of that 150 only 50 are actually "called on".

    If they want to see sales increase, they should add some 1099 reps or fitters this year.
     
  14. Anonymous

    Anonymous Guest

    right on. DME company, clinic based. BV should just open up a compound pharmacy, hire a few Pharm D's, churn out some of that pain cream, make more money and sell the whole shooting match to the highest bidder.
     
  15. Anonymous

    Anonymous Guest

    1099 won't work b/c of medicare fee splitting issues for reps. fitters, maybe, depending on state where located.
     
  16. Anonymous

    Anonymous Guest

    New product? You want to talk about new products?!? (Playoffs)
     
  17. Anonymous

    Anonymous Guest

    I am hearing we are getting out of the ultrasound business. Reimbursement is way down and we have no expertise internally. Another belly flop...
     
  18. Anonymous

    Anonymous Guest

    Wrong. Nice try Sonosite! Lol
     
  19. Anonymous

    Anonymous Guest

    Then why are we letting all the ultrasound reps go?
     
  20. Anonymous

    Anonymous Guest

    It makes sense to get out when contract expires. Not sure whose idea it was for us to sell diagostic ultrasound equipment but it was not a bright decision. It has been costly and major distraction for our sales for our sales force. Another bomb like ScoliScore.
    When will management understand; we are just a DME company. Not capital equipment or biologics. We are Clinical Therapies. Give us our identity Back.